UnitedHealth Group Inc: director John H Noseworthy received 240 shares

What happened John H Noseworthy, a director, received 240 shares as an award (deferred stock units) on Oct 1, 2026. The filing lists the acquisition price as $0.00 per share, total $0. The filing’s footnote states the deferred stock units are granted as regular quarterly director compensation, are immediately vested, and must be retained until the director’s completion of service on the board.

Key details

• Transaction date and price: Oct 1, 2026 — Award/Grant (A), 240 shares at $0.00 per share (total $0).
• Filing date: Oct 5, 2026; report period Oct 1, 2026.
• Shares owned after the transaction: not reported in the filing.
• Footnote: deferred stock units are immediately vested but must be retained until completion of board service.
• No late-filing indicator provided in the data supplied.

Why it may matter This was an award of deferred stock units, not a market purchase or sale. The filing does not show why the insider traded or why the company acted.